Exane Derivatives’s Banco Macro BMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,734
Closed -$45.1K 686
2019
Q3
$45.1K Buy
1,734
+1,500
+641% +$70K 0.01% 372
2019
Q2
$17K Sell
234
-2,367
-91% -$122K ﹤0.01% 432
2019
Q1
$119K Sell
2,601
-525
-17% -$27K 0.02% 279
2018
Q4
$138K Hold
3,126
0.02% 286
2018
Q3
$133K Buy
3,126
+2,093
+203% +$112K 0.03% 292
2018
Q2
$60.1K Buy
+1,033
New +$88.7K 0.01% 375

Other funds holding BMA

Exane Derivatives's BMA Position: Q4 2019 in Review

Exane Derivatives sold out of Banco Macro (BMA) in Q4 2019, closing a stake of 1,734 shares — an estimated $45.1K sold.

Exane Derivatives first reported a position in BMA in Q2 2018 and held it in 6 quarters. The position peaked at $138K in Q4 2018. 103 funds tracked by Wall St. Rank hold BMA as of Q4 2019.

  • Exane Derivatives reported no remaining Banco Macro position as of Q4 2019 after selling out during the quarter.
  • Exane Derivatives sold 1,734 Banco Macro shares in Q4 2019, an estimated $45.1K.
  • Exane Derivatives first reported a position in Banco Macro in Q2 2018 and held it in 6 quarters.
  • Exane Derivatives's Banco Macro position peaked at $138K in Q4 2018.
  • 103 funds tracked by Wall St. Rank held Banco Macro as of Q4 2019.

Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.